Pfizer Financial News

(Reuters) — Bristol Myers (NYSE:BMY) Squibb said on Thursday it plans to double the number of treatments it is testing in clinical trials, with a focus on cell therapies, over the next 18 months, as it contends with increasing generic competition for two of its top-selling drugs.

White House Chief of Staff Jeff Zients on Thursday to discuss refugee resettlement and sponsorship programs, a White House official said. The CEOs will include Alphabet's Sundar Pichai, Walmart's Doug McMillon, Pfizer's Albert Bourla, HP's Enrique Lores and others. They are part of a council of leaders affiliated with Welcome.US, a group dedicated to helping support refugees in the United States.

Investing.com — Stocks lost their earlier upward momentum after August's inflation report came in mostly at expectations, stoking hopes the Federal Reserve is reaching the end of its interest rate increases.

Investing.com — U.S. tech stocks were rising after the annualized core inflation reading for August met expectations, stoking hopes the Federal Reserve is reaching the end of its interest rate increases.

Americans can now get an updated COVID-19 vaccine

Check out the companies making headlines before the bell.

Covid-19 vaccine to protect against the potentially serious outcomes of Covid-19 illness this fall and winter." Bloomberg reported, the statement further added, “Updated Covid-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week." Cohen’s final green light means the shots can be administered across the US. The Food and Drug Administration has already approved them. Distribution of these boosters could be especially helpful for Pfizer, which has struggled amid a sharp decline in sales of its Covid vaccine and antivirals after a surge during the pandemic.

COVID-19 booster shot in hopes of bolstering the nation’s defence against the virus as the fall season approaches.The health regulator on Tuesday approved the updated vaccine made by Moderna for all Canadians aged six months and older. Approval for the updated Pfizer and Novavax vaccine under review has not been announced.The updated mRNA vaccine is tailored to the XBB.1.5 Omicron subvariant that is circulating in the country.

Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, according to a report published by the news agency Reuters. A third shot, made by Novavax, is still under review by the US FDA. However, Novavax did not expect its shot to be authorized in the United States before a meeting of a Centers for Disease Control and Prevention (CDC) advisory panel on Tuesday.

U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter

(Reuters) — The U.S. drug regulator on Monday authorized updated COVID-19 vaccines from Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) that closely match the widely circulating Omicron variants, allowing the deployment of the shots to start as soon as this week.

Atul Goyal, CFO, Brigade Enterprises, says “mid-income housing is doing very well. I will say houses in a price range of around Rs 50-60 lakh to Rs 1.5 crore or so. Our luxury housing is also doing well. There is a lot of demand for that. But 62% to 65% of sales today is in mid-income housing and we think that they should do well going forward and there are reasons for that because there is interest there.”Just wanted to get in a view as to what the outlook is when it comes to the festive season fast approaching. What are the expectations this time around as compared to last year?Expectation is very good.

GlaxoSmithKline Pharmaceuticals Ltd.(up 1.23 per cent), Pfizer Ltd.(up 1.16 per cent), Alkem Laboratories Ltd.(up 0.17 per cent), Sanofi India Ltd.(up 0.17 per cent) and Abbott India Ltd.(up 0.17 per cent) were among the top gainers. Natco Pharma Ltd.(down 1.7 per cent), Aurobindo Pharma Ltd.(down 0.87 per cent), Glenmark Pharmaceuticals Ltd.(down 0.79 per cent), Zydus Lifesciences Ltd.(down 0.62 per cent) and Lupin Ltd.(down 0.52 per cent) were the top losers on the index. The Nifty Pharma index was down 0.2 per cent at 15274.9 at the time of writing this report. Benchmark NSE Nifty50 index was up 55.95 points at 19783.0, while the BSE Sensex was up 224.63 points at 66490.19. Among the 50 stocks in the Nifty index, 32 were trading in the green, while 18 were in the red. Shares of JP Power, Reliance Power, YES Bank, Vodafone Idea and Indian Railway Fin were among the most traded shares on the NSE. Shares of Trans & Rectif, Mazagon Dock Ship, Emmbi Industries, Usha Martin and Graphite India hit their fresh 52-week highs in today's trade, while Penta Gold, Bombay Metrics Suppl, Shubhlaxmi Jewel Art, Panache Digilife and TCNS Clothing hit fresh 52-week lows in trade.

Natixis-backed corporate advisory firm Azure Capital has inducted a new name to its partnership ranks amid a round of promotions.

(Reuters) — Japan-based Astellas Pharma on Wednesday withdrew a lawsuit filed against the U.S. government, days after its prostate cancer drug was spared from the first list of drugs that will be subject to Medicare price negotiations.

A weak party can get a much stronger opponent to back down, game theory explains, by signaling it is willing to take extreme actions and bear steep costs. But that sort of brinkmanship arguably works only if you don’t have to actually fight—and lose—repeatedly. Federal Trade Commission Chair Lina Khan has been open about her willingness to take on hard cases and lose.

By Patrick Wingrove

clinical trial data showed its updated COVID-19 vaccine shot generated an 8.7-fold increase in neutralizing antibodies in humans against the highly-mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections, Reuters reported on Wednesday. “We think this is news people will want to hear as they prepare to go out and get their fall boosters," Reuters quoted Jacqueline Miller head of infectious diseases in Moderna said in an interview, adding that the data should also help reassure regulators.

Joe Biden tested negative for the viral disease, according to a report published by The Associated Press. White House press secretary Karine Jean-Pierre said the president would continue testing regularly and be monitored for symptoms. Jill Biden will remain at the couple's home in Rehoboth Beach, Delaware, for the time being.

The company reported earlier this year that the Covid-19 vaccine was expected to bring in sales of around $13.5bn in 2023, a decline of almost 70% from 2022.

Pfizer, Moderna and Novavax all plan to bring boosters to the market this fall. Pfizer expects to win Food and Drug Administration approval in August, with vaccinations starting in September. Novavax said it expects to get clearance and ship doses in September, and Moderna said it is waiting for approval.